This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holinski-Feder, E.
Right arrow Articles by Meindl, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holinski-Feder, E.
Right arrow Articles by Meindl, A.
Related Collections
Right arrow Infectious Disease & Immunity

PEDIATRICS Vol. 101 No. 2 February 1998, pp. 276-284

Mutation Screening of the BTK Gene in 56 Families With X-Linked Agammaglobulinemia (XLA): 47 Unique Mutations Without Correlation to Clinical Course

Received Apr 3, 1997; accepted Jul 18, 1997.

Elke Holinski-Feder*, Michael WeissDagger , Oliver Brandau*, Kerry B. Jedele*, Beston Nore§, C. Magnus Bäckesjö§, Mauno Vihinenparallel , Stevan R. Hubbard, Bernd H. BelohradskyDagger , C.I. Edvard Smith§, and Alfons Meindl*

From the * Abteilung Medizinische Genetik, Kinderpoliklinik, Klinikum Innenstadt der Universität München, München, Germany; Dagger  Abteilung für Infektionsimmunologie, Dr von Haunersches Kinderspital, Klinikum Innenstadt der Universität München, München, Germany; § Center for BioTechnology, Department of Bioscience at Novum, Karolinska Institute, Huddinge, Sweden; parallel  Department of Biosciences, Division of Biochemistry, University of Helsinki, Helsinki, Finland; and  Department of Pharmacology, New York University Medical Center, New York, New York.

Objectives.  To determine the utility of single-stranded conformation polymorphism (SSCP) analysis for mutation screening in the BTK (Bruton's tyrosine kinase) gene, we investigated 56 X-linked agammaglobulinemia (XLA) families. To obtain genotype/phenotype correlations, predicted protein aberrations were correlated with the clinical course of the disease.

Patients.  This study included 56 patients with XLA, with or without a positive family history, who were diagnosed on the basis of their clinical features, low peripheral B-cell count, and low immunoglobulin levels. Ten patients with isolated hypogammaglobulinemia and 50 healthy males served as controls.

Methods.  SSCP analysis was performed for the entire BTK gene, including the exon-intron boundaries and the promoter region. Structural implications of the missense mutations were investigated by molecular modeling, and the functional consequences of some mutations also were evaluated by in vitro kinase assays and Western blot analysis.

Results.  We report the largest series of patients with XLA to date. All but 5 of the 56 index patients with XLA screened with SSCP analysis showed BTK gene abnormalities, and in 2 of the 5 SSCP-negative patients, no BTK protein was found by Western blot analysis. There were 51 mutations, including 37 novel ones, distributed across the entire gene. This report contains the first promoter mutation as well as 14 novel missense mutations with the first ones described for the Tec homology domain and the glycine-rich motif in the SH1 domain. Each index patient had a different mutation, except for four mutations, each in two unrelated individuals. This result supports the strong tendency for private mutations in this disease. No mutations were found in the controls.

Conclusions.  Our results demonstrate that molecular genetic testing by SSCP analysis provides an accurate tool for the definitive diagnosis of XLA and the discrimination of borderline cases, such as certain hypogammaglobulinemia or common variable immunodeficiency patients with overlapping clinical features. Genotype/phenotype correlations are not currently possible, making prediction of the clinical course based on molecular genetic data infeasible.

Key words: X-linked agammaglobulinemia, mutation, Bruton's tyrosine kinase.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
N. Feldhahn, P. Rio, B. N. B. Soh, S. Liedtke, M. Sprangers, F. Klein, P. Wernet, H. Jumaa, W.-K. Hofmann, H. Hanenberg, et al.
Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells
PNAS, September 13, 2005; 102(37): 13266 - 13271.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
F Rusconi, C Panisi, R M Dellepiane, F Cardinale, L Chini, B Martire, N Bonelli, G Felisati, and M C Pietrogrande
Pulmonary and sinus diseases in primary humoral immunodeficiencies with chronic productive cough
Arch. Dis. Child., December 1, 2003; 88(12): 1101 - 1105.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
I. Bader, O. Brandau, H. Achatz, E. Apfelstedt-Sylla, M. Hergersberg, B. Lorenz, B. Wissinger, B. Wittwer, G. Rudolph, A. Meindl, et al.
X-linked Retinitis Pigmentosa: RPGR Mutations in Most Families with Definite X Linkage and Clustering of Mutations in a Short Sequence Stretch of Exon ORF15
Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1458 - 1463.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
P. P. Sanna and D. R. Burton
Role of Antibodies in Controlling Viral Disease: Lessons from Experiments of Nature and Gene Knockouts
J. Virol., November 1, 2000; 74(21): 9813 - 9817.
[Full Text]